Outcomes of Cochlear Implantation in Pediatrics - Trial NCT04092231
Access comprehensive clinical trial information for NCT04092231 through Pure Global AI's free database. This phase not specified trial is sponsored by Amira Mohmed Ahmed Bakr and is currently Not yet recruiting. The study focuses on Hearing Impaired Children. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Amira Mohmed Ahmed Bakr
Assiut University
Timeline & Enrollment
N/A
May 01, 2020
Dec 30, 2022
Primary Outcome
change in percent correct in speech perception as measured with single words presented in a closed set
Summary
The cochlear implant (CI) is the most important progress in the treatment for adults and
 children with severe to profound bilateral sensorineural hearing loss who do not receive
 adequaยฌte benefit from hearing aids and making possible better results in auditory,
 linguistic, social and academic development.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04092231
Non-Device Trial

